Subsidiary Khure Health’s Clinical Clarity offering enhances accredited learning for physicians and drives full practice Quality Improvement
TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- MCI Onehealth Technologies Inc. (“MCI”) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, and Khure Health, an MCI wholly-owned subsidiary that provides artificial intelligence-based patient screening solutions, are pleased to announce the launch of Clinical Clarity, a resource for significantly enhanced physician continuing medical education (CME) that has immediate impact on patient care pathways.
Clinical Clarity is now offered on Khure Health’s platform, which is North America’s most advanced AI-enabled clinical decision support software with over 100 disease specific algorithms and educational content. Through Clinical Clarity, Khure Health now offers an evolutionary advancement in CME delivery, allowing physicians to take certified CME courses from within the Khure platform and, with the click of a button, immediately apply their learning across their entire practice to improve patient care.
“MCI’s tech and data-enabled high-performance healthcare network helps address urgent health system issues. With Khure Health’s innovative CME delivery via Clinical Clarity, we’re providing a much-needed service to overburdened doctors, while empowering them to immediately optimize the care of their patients at risk of rare, complex and chronic disease,” said Dr. Alexander Dobranowski, CEO of MCI.
The Ministry of Health and Long-Term Care and Ontario Health are working together to align quality improvement efforts to better reflect current priorities and health system changes, and some medical organizations have existing legislative and/or contractual obligations to complete clinical Quality Improvement Plans (QIPs). Clinical Clarity offers physicians the ability to efficiently develop and complete QIPs through the use of Khure’s advanced technology.
“Certified CME is required for physicians to maintain their licensing. But traditional CME has historically been inconvenient, overly time-consuming and often difficult to implement across an entire practice given the need to manually screen through patient charts to identify appropriate patients and then take appropriate actions with extensive documentation. This is where advanced technology can help. Physicians taking these courses and health stakeholders supporting and sponsoring CME need a better solution,” said Don Watts, President of Khure Health. “With Clinical Clarity, efficient learning can be enhanced and immediately applied to optimize the care of appropriate patients in a physician’s practice. It is potentially game changing for physicians who are immensely over-burdened these days, but still need to continue to educate themselves as medical science progresses.”
Khure Health’s Clinical Clarity offering is part of MCI’s growing suite of data-driven solutions. Currently, MCI provides data insights as a service in six categories: rare disease; complex major medical/chronic; patient cohort building; clinical trial recruitment; synthetic health data and bespoke insights. Such services are targeted at pharmaceutical companies, life science companies, precision medicine companies and top-tier university centres, providing access to valuable insights to improve care and inform commercial, medical and market access strategies.
“MCI is, yet again, proud to be transforming primary care delivery with precision medicine technologies, novel referral optimization and custom tech-forward initiatives. We’re confident that we’ll see interest in Clinical Clarity from primary care physicians, specialists, physician societies, and the many sponsors of CME programming,” added Dobranowski.
MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. As part of the healthcare community for over 30 years, MCI operates one of Canada’s leading primary care networks with nearly 260 physicians and specialists, serves more than one million patients annually and had nearly 300,000 telehealth visits last year, including online visits via mciconnect.ca. MCI additionally offers an expanding suite of occupational health service offerings that support a growing list of nearly 600 corporate customers. Led by a proven management team of doctors and experienced executives, MCI remains focused on executing a strategy centered around acquiring technology and health services that complement the company’s current roadmap. For more information, visit mcionehealth.com.
For media enquiries please contact:
Nolan Reeds | email@example.com
Forward Looking Statements
Certain statements in this press release, constitute “forward-looking information” and "forward looking statements" (collectively, "forward looking statements") within the meaning of applicable Canadian securities laws and are based on assumptions, expectations, estimates and projections as of the date of this press release. Forward-looking statements include statements with respect to the anticipated health benefits, cost savings and other advantages of MCI’s collaboration with Oro Health, and references to other similar programs that are underway. The words “to increase”, “potentially”, “to help”, “expect”, “estimate”, “underway”, “expand”, “accelerate”, “create”, “goal”, “possibility”, “growing” or variations of such words and phrases or statements that certain future conditions, actions, events or results “will”, “may”, “could”, “would”, “should”, “might” or “can”, or negative versions thereof, “occur”, “continue” or “be achieved”, and other similar expressions, identify forward-looking statements. Forward-looking statements are necessarily based upon management’s perceptions of historical trends, current conditions and expected future developments, as well as a number of specific factors and assumptions that, while considered reasonable by MCI as of the date of such statements, are outside of MCI's control and are inherently subject to significant business, economic and competitive uncertainties and contingencies which could result in the forward-looking statements ultimately being entirely or partially incorrect or untrue. Forward looking statements contained in this press release are based on various assumptions, including, but not limited to, the following: MCI’s ability to maintain its relationships and continue to implement its collaborations with ORO Health and other potential collaborators; the effects of competition in the industry; the requirement for increasingly innovative product solutions and service offerings; trends in customer growth; sufficiency of current working capital to support future operating and working capital requirements; the stability of general economic and market conditions; currency exchange rates and interest rates; MCI's ability to comply with applicable laws and regulations; MCI's continued compliance with third party intellectual property rights; the anticipated effects of COVID-19; and that the risk factors noted below, collectively, do not have a material impact on MCI's business, operations, revenues and/or results. By their nature, forward-looking statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct, and that objectives, strategic goals and priorities will not be achieved.
Known and unknown risk factors, many of which are beyond the control of MCI, could cause the actual results of MCI to differ materially from the results, performance, achievements or developments expressed or implied by such forward-looking statements. Such risk factors include but are not limited to those factors which are discussed under the section entitled “Risk Factors” in MCI's annual information form dated March 31, 2022, which is available under MCI's SEDAR profile at www.sedar.com. The risk factors are not intended to represent a complete list of the factors that could affect MCI and the reader is cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Forward-looking statements are provided for the purpose of providing information about management’s expectations and plans relating to the future. MCI disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, or to explain any material difference between subsequent actual events and such forward-looking statements, except to the extent required by applicable law. All of the forward-looking statements contained in this press release are qualified by these cautionary statements.